查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571770

CBD 營養保健品市場規模、佔有率、趨勢分析報告：按產品、按應用、按分銷管道、按地區、細分市場預測，2024-2030 年

CBD Nutraceuticals Market Size, Share & Trends Analysis Report By Product (CBD Tinctures, Capsules & Softgels), By Application, By Distribution Channel (Retail Stores, Online), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

CBD 營養保健品市場成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球 CBD 營養保健品市場規模預計將達到 231.7 億美元，2024 年至 2030 年複合年成長率為 14.2%。

2018 年農業法案的訂定，使大麻種植和大麻衍生產品在美國合法化，消費者對營養保健品中植物來源的偏好不斷增加，以及對大麻二酚健康益處的認知正在推動市場成長，這些都是推動市場成長的因素。然而，替代產品的可用性阻礙了市場的成長。

CBD 酊劑細分市場在全球市場佔據主導地位，2023 年佔收益佔有率的 41.9%。人們越來越接受大麻二酚用於健康和保健目的，再加上舌下給藥時酊劑的高生物利用度，是這一巨大市場佔有率背後的主要因素。另一方面，膠囊和軟膠囊預計將成為預測期內成長最快的產品類型，因為它們適合旅行且方便在公共場所攜帶。然而，許多消費者不喜歡大麻二酚的原始味道和質地，轉而使用膠囊和軟膠囊。

從銷售管道來看，2023年零售領域將主導市場，因為消費者更喜歡在零售店購買營養保健品。另一方面，由於人們對網路購物的偏好不斷上升，因此預計線上銷售管道在預測期內將以最快的複合年成長率擴張。此外，CBD 營養保健品領域的新進業者發現線上銷售管道是比零售店更經濟的選擇。

CBD 營養保健品市場報告亮點

  • CBD 酊劑細分市場在全球市場佔據主導地位，2023 年佔收益佔有率的 41.9%。為健康問題提供有效解決方案的能力，例如針對慢性疼痛、憂鬱症和藥物濫用障礙的治療支持，緩解某些癌症症狀的能力以及可用性正在推動這一領域的成長。
  • 2023年，食用和強化食品領域佔據最大的銷售佔有率。這一成長歸因於 CBD食品配方的進步以及消費者對其健康益處的認知的提高。
  • 2023 年，零售店細分市場將主導全球市場。便利性、多種選擇的可用性以及主要企業對提高品牌知名度的偏好都有助於零售店領域的成長。
  • 北美 CBD 營養保健品市場在全球產業中佔據主導地位，2023 年收益佔有率為 54.5%。該市場主要是由消費者意識的提高、CBD在各種應用中的日益採用以及美國和加拿大等國家的積極監管情況所推動的。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 CBD 營養保健品市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • CBD 保健品市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 CBD 營養保健品市場：產品評估與趨勢分析

  • 細分儀表板
  • CBD 營養保健品市場：2023 年和 2030 年產品變化分析
  • CBD酊劑
  • 膠囊和軟膠囊
  • CBD 軟糖
  • 其他

第5章 CBD 營養保健品市場：使用量估計與趨勢分析

  • 細分儀表板
  • CBD 營養保健品市場：2023 年和 2030 年應用變化分析
  • 食用食品和強化食品
  • 培訓補充品
  • 健康
  • 其他

第 6 章 CBD 保健品市場：通路估計與趨勢分析

  • 細分儀表板
  • CBD 保健品市場：2023 年和 2030 年通路變化分析
  • 零售店
  • 線上
  • 藥局

第7章 CBD 保健品市場：區域估計與趨勢分析

  • 2023 年及 2030 年 CBD 營養保健品市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Charlotte's Web, Inc.
    • Elixinol
    • Medical Marijuana, Inc.
    • CV Sciences, Inc.
    • Irwin Naturals
    • Diamond CBD.
    • Foria Wellness（Eden Partners LLC）
    • Medterra CBD
    • Green Roads
    • Isodiol International Inc
簡介目錄
Product Code: GVR-4-68038-156-6

CBD Nutraceuticals Market Growth & Trends:

The global CBD nutraceuticals market size is expected to reach USD 23.17 billion by 2030, registering a CAGR of 14.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Introduction of the 2018 Farm Bill that legalized hemp cultivation and hemp-derived products in U.S., rising consumer preference for plant-based ingredients in dietary supplements, and awareness regarding the health benefits of cannabidiol are some of the factors powering the market growth. However, the easy availability of alternative products is obstructing market growth.

CBD tinctures segment dominated the global market and accounted for a revenue share of 41.9% in 2023. Increasing acceptance of cannabidiol for health and wellness purposes coupled with high bioavailability of tinctures when administered sublingually are the major factors responsible for this large market share. On the other hand, capsules and soft gels are anticipated to be the fastest-growing product type over the forecast period, as they are travel-friendly and convenient to carry in public places. However, many consumers dislike the raw taste and texture of cannabidiol and so they are switching towards capsules and softgels.

Based on the distribution channel, retail store segment dominated the market in 2023, as consumers prefer retail stores for buying dietary supplements due to attractive pricing. On the other hand, the online sales channel is expected to expand at the fastest CAGR over the forecast period owing to the rise in the preference for online shopping. Furthermore, the new entrants in the CBD nutraceuticals space, find online sales channel a much economical alternative than a retail storefront.

CBD Nutraceuticals Market Report Highlights:

  • CBD tinctures segment dominated the global market and accounted for a revenue share of 41.9% in 2023. The ability of the product to provide effective solutions for health problems, such as assistance in treatments of chronic pain, depression, and substance use disorders, the capacity to alleviate specific cancer symptoms, and ease of availability, contribute to this segment's growth.
  • The edibles and fortified foods segment accounted for the largest revenue share in 2023. The growth is attributed to advancements in formulations of CBD foods and growing awareness among consumers about its health benefits.
  • Retail stores segment dominated the global market in 2023. Ease of accessibility, availability of multiple alternatives, and preference by key companies in order to accomplish enhanced brand visibility have contributed to the growth of retail store segment.
  • North America CBD nutraceuticals market dominated the global industry with a revenue share of 54.5% in 2023. This market is primarily driven by rising consumer awareness, increased adoption of CBD in various applications, and positive regulatory scenarios in countries such as the U.S. and Canada.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. CBD Nutraceuticals Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. CBD Nutraceuticals Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. CBD Nutraceuticals Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. CBD Nutraceuticals Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. CBD Tinctures
    • 4.3.1. CBD Tinctures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Capsules & Softgels
    • 4.4.1. Capsules & Softgels Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. CBD Gummies
    • 4.5.1. CBD Gummies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. CBD Nutraceuticals Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. CBD Nutraceuticals Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Edible and Fortified Foods
    • 5.3.1. Edible and Fortified Foods Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Workout Supplements
    • 5.4.1. Workout Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Wellness
    • 5.5.1. Wellness Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. CBD Nutraceuticals Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. CBD Nutraceuticals Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Retail Stores
    • 6.3.1. Retail Stores Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Online
    • 6.4.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Pharmacies
    • 6.5.1. Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. CBD Nutraceuticals Market: Regional Estimates & Trend Analysis

  • 7.1. CBD Nutraceuticals Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. China CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. South Korea CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Charlotte's Web, Inc.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Elixinol
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Medical Marijuana, Inc.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. CV Sciences, Inc.
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Irwin Naturals
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Diamond CBD.
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Foria Wellness (Eden Partners LLC)
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Medterra CBD
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Green Roads
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Isodiol International Inc
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives